Hormone therapy with antiandrogens has been used therapeutically in prostate cancer patients.23 Some of the commonly used antiandrogens (eg, bicalutamide) competitively inhibit ligand binding to the active AR. This evidence concerns the gene AR and prostate carcinoma.